What is the price target for ENTX stock?
7 analysts have analysed ENTX and the average price target is 10.2 USD. This implies a price increase of 655.56% is expected in the next year compared to the current price of 1.35.
ENTERA BIO LTD (ENTX) Forecast, Price Target & Analyst Ratings
NASDAQ:ENTX • IL0011429839
Current stock price
1.35 USD
+0.08 (+6.3%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ENTERA BIO LTD (ENTX).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 27, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.09
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$10.20
Upside
+ 655.56%
From current price of $1.35 to mean target of $10.20, Based on 7 analyst forecasts
Low
$10.10
Median
$10.20
High
$10.50
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for ENTX. The average price target is 10.2 USD. This implies a price increase of 655.56% is expected in the next year compared to the current price of 1.35.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
ENTX was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ENTX.
In the previous month the buy percentage consensus was at a similar level.
ENTX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-04 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-28 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-09-06 | HC Wainwright & Co. | Initiate | Buy |
| 2022-07-19 | B. Riley Securities | Maintains | Buy |
| 2021-06-16 | B. Riley Securities | Initiate | Buy |
| 2021-03-22 | Aegis Capital | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 27, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.09
- Revenue Estimate
- Revenue Q2Q
- -100.00%
- EPS Q2Q
- -53.00%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
18.18%
Next Earnings Summary
ENTX is expected to report earnings on 3/27/2026. The consensus EPS estimate for the next earnings is -0.09 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 130K -77.19% | -100.00% | 181K | 42.84K -76.33% | N/A | |
| EBITDA YoY % growth | -12.96M -6.49% | -8.835M 31.83% | -9.539M -7.97% | N/A | N/A | |
| EBIT YoY % growth | -13.02M -6.55% | -8.891M 31.71% | -9.585M -7.81% | -13.043M -36.07% | -34.68M -165.90% | |
| Operating Margin | -10,015.38% | N/A | -5,295.58% | -30,445.24% | N/A | |
| EPS YoY % growth | -0.45 27.42% | -0.31 31.11% | -0.25 19.35% | -0.29 -14.24% | -0.69 -142.86% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.09 -53.00% | -0.15 -355.00% | -0.17 -189.00% | -0.17 -147.71% | -0.18 -100.00% |
| Revenue Q2Q % growth | -100.00% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.386M -87.68% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ENTERA BIO LTD / ENTX Forecast FAQ
Can you provide the upcoming earnings date for ENTERA BIO LTD?
ENTERA BIO LTD (ENTX) will report earnings on 2026-03-27, after the market close.
What are the consensus estimates for ENTERA BIO LTD (ENTX) next earnings?
The consensus EPS estimate for the next earnings of ENTERA BIO LTD (ENTX) is -0.09 USD and the consensus revenue estimate is 0 USD.